Initiation of Inhaled Corticosteroid and Long-Acting b2-adrenergic Agonist …
AJMC.com Managed Markets Network Study Design: The current study is a retrospective cohort analysis of patients with asthma, aged 12 to 64 years, new to ICS/LABA combination therapy, using—US healthcare claims data between June 1, 2007, and December 31, 2010. Methods: Patients with … |
View full post on asthma – Google News